Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Teitelbaum Law Group
- Blitman & King
- Simmons Hanly
- Burke Warren
- Godfrey & Kahn
- Pillsbury Winthrop
- Gilbert LLP
- Davis Polk
- Goodwin Procter
- Himes Petrarca
- BatesCarey
- Lowe Stein
- McDermott Will & Schulte
- Porter Hedges
- Gage Spencer & Fleming
- Consovoy McCarthy
- Gertz & Rosen
- Porteous Hainkel
- Andrews & Thornton
- Skadden Arps
- Phillips Lytle
- ASK LLP
- Joseph Hage
- Spangenberg Shibley
- Cuneo Gilbert
- Motley Rice
- WestLoop Law
- Faegre Drinker
- Morgan Lewis
- King & Spalding
- Mintz Levin
- Slevin & Hart
- WilmerHale
- Doshi Legal Group
- Foley & Lardner
- Bentley & Bruning
- Pachulski Stang
- Lerner Arnold
- Kramer Levin
- Brown Rudnick
- Bialson Bergen
- Bielli & Klauder
- Stevens & Lee
- White & Case
- Martin S. Rapaport
- Marino Tortorella
- Cronin Fried
- Potter Anderson
- Crowell & Moring
- Kirkland & Ellis
- Duane Morris
- Saul Ewing
- Arnold & Porter
- Wilk Auslander
- Stutzman Bromberg
- McGrail & Bensinger
- Jones Day
- Brown & Connery
- Hagens Berman
- Miller Nash LLP
- Kobre & Kim
- Porzio Bromberg
- Napoli Shkolnik
- Robins Kaplan
- Marcus & Shapira
- Dentons
- Ballard Spahr
- Shook Hardy
- Debevoise & Plimpton
- Shafferman & Feldman
- Hughes Socol
- Reed Smith
- Pashman Stein
- Keller Rohrback
- O'Melveny & Myers
- Willkie Farr
- Seyfarth Shaw
- Loeb & Loeb
- UB Greensfelder
- Kleinberg Kaplan
- Katsky Korins
- Clifford Law Offices
- Barack Ferrazzano
- Terrell Hogan
- Sherrard Roe
- Levenfeld Pearlstein
- Rothstein Mandell
- Doster Ullom
- MacElree Harvey
- Blank Rome
- Hurwitz Fine
- Keller Postman
- Pullman & Comley
- Cleary Gottlieb
- Mehri & Skalet
- MoloLamken
- Troutman
- Tarter Krinsky
- Tate Law Group LLC
- Klehr Harrison
- Frost Brown
- ArentFox Schiff
- Taft Stettinius
- Lowey Dannenberg
- Williams Mullen
- Wachtell Lipton
- Waldrep Wall
- Dechert LLP
- Quinn Emanuel
- Ifrah Law
- Seward & Kissel
- Simpson Thacher & Bartlett LLP
- Lite DePalma
- Squire Patton
- White Coleman & Associates
- Caplin & Drysdale
- Miller Shah
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
Companies
- Teamsters Local 456
- AXA XL Ltd.
- Johnson & Johnson
- Henry Schein Inc.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Otis Worldwide Corp.
- Impax Laboratories, Inc.
- Kodiak Area Native Association
- Ranbaxy
- Tucson Medical Center
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- McKesson Corp.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Omnicare Inc.
- Endo International PLC
- Giant Eagle Inc.
- Bausch Health Cos. Inc.
- Province LLC
- United Parcel Service Inc.
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- Cencora Inc.
- Express Scripts Holding Co.
- Hain Capital Group LLC
- Walmart Inc.
- KVK Tech Inc.
- Amneal Pharmaceuticals Inc.
- Loblaw Cos.
- TR Capital Management LLC
- The Cigna Group
- Ironshore Inc.
- Noramco Inc.
- Alaska Native Tribal Health Consortium
- Anda Inc.
- AlixPartners LLP
- Allergan PLC
- Purdue Pharma LP
- CVS Health Corp.
- United Food & Commercial Workers International Union
- Viatris Inc.
- FTI Consulting Inc.
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- DuPont de Nemours Inc.
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- State of Indiana
- Seldovia Village Tribe
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- Pala Band of Mission Indians
- U.S. District Court for the District of Columbia
- Town of Ramapo, New York
- City of Bayonne, New Jersey
- Commonwealth of Massachusetts
- State of Nevada
- Washington State Department of Revenue
- Nez Perce Tribe
- Port Gamble S'Klallam Tribe
- Borough of Paramus, New Jersey
- Jamestown S'Klallam Tribe
- Northwestern Band of the Shoshone Nation
- St. Regis Mohawk Tribe
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Hopi Tribe
- Tennessee Attorney General's Office
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
September 24, 2021
California AG Announces Appeal Of Purdue Ch. 11 Plan
California Attorney General Rob Bonta on Friday became the latest attorney general to announce an appeal of the approval of Purdue Pharma's Chapter 11 plan, saying the OxyContin maker's former owners in the Sackler family must be held accountable for their part in the opioid crisis.
-
September 22, 2021
US Trustee Challenges Constitutionality Of Purdue Releases
The nondebtor, third-party releases included in Purdue Pharma's Chapter 11 plan are unconstitutional, the U.S. Trustee's Office has argued, asking a New York bankruptcy judge to wait until a higher court rules on the federal watchdog's challenge to the releases.
-
September 16, 2021
US Trustee To Appeal Sackler Releases In Purdue Ch. 11
The U.S. Trustee's Office has told a New York bankruptcy judge it will appeal his order approving Purdue Pharma's Chapter 11 plan, saying the plan's liability releases for Purdue's Sackler family now-former owners go beyond the law and undermine confidence in the system.
-
September 13, 2021
Purdue Pharma Gets OK For $7.1M In Exec Incentives
A New York bankruptcy judge gave Purdue Pharma permission Monday to make incentive payments of up to $7.1 million to its top executives, rejecting arguments that the executives had not done enough to clean up the company's corporate culture.
-
September 01, 2021
Purdue Pharma Ch. 11 Plan Gets OK With Sackler Releases
A New York bankruptcy judge on Wednesday approved OxyContin maker Purdue Pharma's Chapter 11 plan, including contentious opioid liability releases for the company's now-former Sackler family owners.
-
August 27, 2021
Sacklers Agree To Forgo Non-Opioid Ch. 11 Releases
Purdue Pharma told a New York bankruptcy judge on Friday that its owners in the Sackler family will no longer be getting releases for non-opioid liability, but liability immunity related to opioid claims will remain, as the hearing on the final decision on its Chapter 11 plan has been postponed.
-
August 25, 2021
Purdue Ch. 11 Judge Says Sackler Releases Should Be Tighter
A New York bankruptcy judge on Wednesday urged Purdue Pharma to narrow the nonopioid liability releases it is granting members of its owning Sackler family as he prepared to make his judgment on Purdue's Chapter 11 plan on Friday.
-
August 23, 2021
No More Speeches, Settle This Ch. 11, Purdue Judge Urges
Telling the parties Monday that "the time has passed at this point to speechify," the New York bankruptcy judge overseeing Purdue Pharma's bankruptcy urged the objecting states and the owning members of the Sackler family to settle their differences before the confirmation hearing resumes Wednesday.
-
August 19, 2021
Judge Urges Attention To Individual Stories In Purdue Ch. 11
The sixth day of evidence in Purdue Pharma's Chapter 11 plan confirmation hearing ended Thursday with the judge walking off camera after a declaration that the damage individuals have suffered in the opioid crisis should not be lost in the complexities of the bankruptcy case.
-
August 18, 2021
Ex-Purdue Chair Denies Blame For Opioid Crisis
A former president and board chairman of Purdue Pharma on Wednesday denied that the company or its owners in the Sackler family bore responsibility for the United States' opioid crisis as the confirmation hearing for Purdue's Chapter 11 plan entered its fifth day.